H&R GMBH & CO KGAA (2HRA.DE) Fundamental Analysis & Valuation

FRA:2HRA • DE000A2E4T77

Current stock price

4.2 EUR
-0.1 (-2.33%)
Last:

This 2HRA.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. 2HRA.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 2HRA was profitable.
  • 2HRA had a positive operating cash flow in the past year.
  • Of the past 5 years 2HRA 4 years were profitable.
  • In the past 5 years 2HRA always reported a positive cash flow from operatings.
2HRA.DE Yearly Net Income VS EBIT VS OCF VS FCF2HRA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • 2HRA has a worse Return On Assets (0.40%) than 61.43% of its industry peers.
  • 2HRA has a Return On Equity of 0.95%. This is in the lower half of the industry: 2HRA underperforms 61.43% of its industry peers.
  • 2HRA's Return On Invested Capital of 2.43% is in line compared to the rest of the industry. 2HRA outperforms 45.71% of its industry peers.
  • 2HRA had an Average Return On Invested Capital over the past 3 years of 4.21%. This is below the industry average of 6.99%.
Industry RankSector Rank
ROA 0.4%
ROE 0.95%
ROIC 2.43%
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
2HRA.DE Yearly ROA, ROE, ROIC2HRA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

  • 2HRA has a worse Profit Margin (0.31%) than 62.86% of its industry peers.
  • 2HRA's Profit Margin has declined in the last couple of years.
  • 2HRA's Operating Margin of 2.18% is on the low side compared to the rest of the industry. 2HRA is outperformed by 64.29% of its industry peers.
  • In the last couple of years the Operating Margin of 2HRA has grown nicely.
  • 2HRA has a worse Gross Margin (24.46%) than 64.29% of its industry peers.
  • 2HRA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.18%
PM (TTM) 0.31%
GM 24.46%
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
2HRA.DE Yearly Profit, Operating, Gross Margins2HRA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. 2HRA.DE Health Analysis

2.1 Basic Checks

  • 2HRA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, 2HRA has about the same amount of shares outstanding.
  • The number of shares outstanding for 2HRA remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for 2HRA has been reduced compared to a year ago.
2HRA.DE Yearly Shares Outstanding2HRA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
2HRA.DE Yearly Total Debt VS Total Assets2HRA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 2.11 indicates that 2HRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • 2HRA's Altman-Z score of 2.11 is in line compared to the rest of the industry. 2HRA outperforms 47.14% of its industry peers.
  • The Debt to FCF ratio of 2HRA is 33.63, which is on the high side as it means it would take 2HRA, 33.63 years of fcf income to pay off all of its debts.
  • 2HRA has a worse Debt to FCF ratio (33.63) than 61.43% of its industry peers.
  • 2HRA has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.13, 2HRA is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 33.63
Altman-Z 2.11
ROIC/WACC0.44
WACC5.48%
2HRA.DE Yearly LT Debt VS Equity VS FCF2HRA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • 2HRA has a Current Ratio of 1.42. This is a normal value and indicates that 2HRA is financially healthy and should not expect problems in meeting its short term obligations.
  • 2HRA's Current ratio of 1.42 is on the low side compared to the rest of the industry. 2HRA is outperformed by 65.71% of its industry peers.
  • 2HRA has a Quick Ratio of 1.42. This is a bad value and indicates that 2HRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.75, 2HRA is doing worse than 74.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.75
2HRA.DE Yearly Current Assets VS Current Liabilites2HRA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. 2HRA.DE Growth Analysis

3.1 Past

  • The earnings per share for 2HRA have decreased strongly by -30.03% in the last year.
  • Measured over the past years, 2HRA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -40.40% on average per year.
  • The Revenue has decreased by -3.07% in the past year.
  • The Revenue has been growing slightly by 4.47% on average over the past years.
EPS 1Y (TTM)-30.03%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%-122.22%
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%-8.14%

3.2 Future

  • 2HRA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.24% yearly.
  • 2HRA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.42% yearly.
EPS Next Y-68.8%
EPS Next 2Y-16.63%
EPS Next 3Y-0.24%
EPS Next 5YN/A
Revenue Next Year-5.19%
Revenue Next 2Y-1.92%
Revenue Next 3Y-0.42%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
2HRA.DE Yearly Revenue VS Estimates2HRA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
2HRA.DE Yearly EPS VS Estimates2HRA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

2

4. 2HRA.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 42.00, the valuation of 2HRA can be described as expensive.
  • 62.86% of the companies in the same industry are cheaper than 2HRA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of 2HRA to the average of the S&P500 Index (25.96), we can say 2HRA is valued expensively.
  • The Price/Forward Earnings ratio is 25.21, which means the current valuation is very expensive for 2HRA.
  • Based on the Price/Forward Earnings ratio, 2HRA is valued a bit more expensive than the industry average as 61.43% of the companies are valued more cheaply.
  • 2HRA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 42
Fwd PE 25.21
2HRA.DE Price Earnings VS Forward Price Earnings2HRA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 2HRA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as 2HRA.
Industry RankSector Rank
P/FCF 32.67
EV/EBITDA 2.51
2HRA.DE Per share data2HRA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.63%
EPS Next 3Y-0.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. 2HRA.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.34%, 2HRA has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.38, 2HRA has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.91, 2HRA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.34%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
2HRA.DE Yearly Dividends per share2HRA.DE Yearly Dividends per shareYearly Dividends per share 2018 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

  • 2HRA pays out 94.56% of its income as dividend. This is not a sustainable payout ratio.
DP94.56%
EPS Next 2Y-16.63%
EPS Next 3Y-0.24%
2HRA.DE Yearly Income VS Free CF VS Dividend2HRA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
2HRA.DE Dividend Payout.2HRA.DE Dividend Payout, showing the Payout Ratio.2HRA.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

2HRA.DE Fundamentals: All Metrics, Ratios and Statistics

H&R GMBH & CO KGAA

FRA:2HRA (3/16/2026, 7:00:00 PM)

4.2

-0.1 (-2.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)03-31
Inst Owners1.49%
Inst Owner ChangeN/A
Ins Owners6.06%
Ins Owner ChangeN/A
Market Cap156.32M
Revenue(TTM)1.29B
Net Income(TTM)3.94M
Analysts36.36
Price Target4.69 (11.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.34%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP94.56%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-12%
EPS NY rev (3m)-12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 42
Fwd PE 25.21
P/S 0.12
P/FCF 32.67
P/OCF 2.39
P/B 0.38
P/tB 0.41
EV/EBITDA 2.51
EPS(TTM)0.1
EY2.38%
EPS(NY)0.17
Fwd EY3.97%
FCF(TTM)0.13
FCFY3.06%
OCF(TTM)1.76
OCFY41.82%
SpS34.61
BVpS11.09
TBVpS10.33
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5
Profitability
Industry RankSector Rank
ROA 0.4%
ROE 0.95%
ROCE 4.1%
ROIC 2.43%
ROICexc 2.75%
ROICexgc 2.88%
OM 2.18%
PM (TTM) 0.31%
GM 24.46%
FCFM 0.37%
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
ROICexc(3y)4.64%
ROICexc(5y)4.53%
ROICexgc(3y)4.9%
ROICexgc(5y)4.79%
ROCE(3y)7.11%
ROCE(5y)6.95%
ROICexgc growth 3Y-25.59%
ROICexgc growth 5Y22.95%
ROICexc growth 3Y-25.37%
ROICexc growth 5Y23.82%
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 33.63
Debt/EBITDA 0.59
Cap/Depr 98.21%
Cap/Sales 4.7%
Interest Coverage 3.72
Cash Conversion 72.84%
Profit Quality 121.57%
Current Ratio 1.42
Quick Ratio 0.75
Altman-Z 2.11
F-Score5
WACC5.48%
ROIC/WACC0.44
Cap/Depr(3y)102.18%
Cap/Depr(5y)93.34%
Cap/Sales(3y)4.27%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.03%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%-122.22%
EPS Next Y-68.8%
EPS Next 2Y-16.63%
EPS Next 3Y-0.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%-8.14%
Revenue Next Year-5.19%
Revenue Next 2Y-1.92%
Revenue Next 3Y-0.42%
Revenue Next 5YN/A
EBIT growth 1Y3.84%
EBIT growth 3Y-23.19%
EBIT growth 5Y31.47%
EBIT Next Year167.45%
EBIT Next 3Y43.78%
EBIT Next 5YN/A
FCF growth 1Y-94.25%
FCF growth 3YN/A
FCF growth 5Y-5.95%
OCF growth 1Y-56.02%
OCF growth 3Y23.36%
OCF growth 5Y-6.03%

H&R GMBH & CO KGAA / 2HRA.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for H&R GMBH & CO KGAA?

ChartMill assigns a fundamental rating of 2 / 10 to 2HRA.DE.


What is the valuation status for 2HRA stock?

ChartMill assigns a valuation rating of 2 / 10 to H&R GMBH & CO KGAA (2HRA.DE). This can be considered as Overvalued.


Can you provide the profitability details for H&R GMBH & CO KGAA?

H&R GMBH & CO KGAA (2HRA.DE) has a profitability rating of 3 / 10.


What is the financial health of H&R GMBH & CO KGAA (2HRA.DE) stock?

The financial health rating of H&R GMBH & CO KGAA (2HRA.DE) is 3 / 10.


Can you provide the expected EPS growth for 2HRA stock?

The Earnings per Share (EPS) of H&R GMBH & CO KGAA (2HRA.DE) is expected to decline by -68.8% in the next year.